Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians

被引:63
作者
Ahluwalia, Tarunveer Singh [2 ]
Ahuja, Monica [1 ]
Rai, Taranjit Singh [1 ]
Kohli, Harbir Singh [2 ]
Sud, Kamal [2 ]
Bhansali, Anil [3 ]
Khullar, Madhu [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh 160012, India
关键词
diabetic nephropathy; type; 2; diabetes; eNOS gene polymorphisms; eNOS haplotypes; endothelial nitric oxide synthase gene;
D O I
10.1007/s11010-008-9759-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease, including diabetic nephropathy. Endothelial-derived nitric oxide synthase (eNOS) gene polymorphisms affect eNOS activity and are associated with endothelial dysfunction. We evaluated the association of the constitutive endothelial nitric oxide synthase gene (eNOS) polymorphisms with type 2 diabetic nephropathy. We genotyped three polymorphisms of eNOS (Two SNPs: -786T > C, 894G > T and one 27-bp repeat polymorphism in Intron 4 (27VNTR)) in type 2 diabetic nephropathy patients (cases: n = 195) and type 2 diabetic without nephropathy (controls: n = 255), using validated PCR-RFLP assays. We measured serum NO levels in these subjects and examined its correlation with diabetic nephropathy and eNOS genotypes. The frequency of CC (-786T > C), TT (894G > T) and aa genotypes (27VNTR) were significantly higher in diabetic nephropathy patients as compared to the diabetes without nephropathy group (CC: P = 0.003, TT: P = 0.03, aa: P < 0.0001). These mutant genotypes were found to be associated with higher risk of nephropathy (-786T > C: OR: 5.5, 95%CI: 1.53-19.79; 894G > T: OR: 1.8, 95%CI: 1.03-3.16; Intron 4: OR: 6.23, 95%CI: 2.23-16.31). Haplotype with all the wild alleles (T-b-G) was found to be associated with a decreased risk of nephropathy (OR: 0.68, P = 0.005) and haplotype with all mutant alleles (C-a-T) was associated with higher risk of diabetic nephropathy as compared to diabetes without nephropathy group (OR: 2.6, P = 0.14). No significant linkage disequilibria were observed among the variants in this case-control study. The serum NO levels were observed to be significantly (P < 0.05) lower in mutant allele carriers ('C' allele of T-786C SNP and/or 'T' allele of G894T SNP) as compared with the wild-type allele carriers (-786T and/or 894G) within each of the subject groups (with and without nephropathy). These results suggest that the eNOS gene locus is associated with diabetic nephropathy and the functional polymorphisms (-786T > C & 894G > T) might lead to a decreased expression of eNOS gene.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 53 条
[1]   T-786→C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease [J].
Asakimori, Y ;
Yorioka, N ;
Taniguchi, Y ;
Ito, T ;
Ogata, S ;
Kyuden, Y ;
Kohno, N .
NEPHRON, 2002, 91 (04) :747-751
[2]   Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease [J].
Asakimori, Y ;
Yorioka, N ;
Yamamoto, I ;
Okumoto, S ;
Doi, S ;
Hirai, T ;
Taniguchi, Y .
NEPHRON, 2001, 89 (02) :219-223
[3]   ROLE OF EDRF (NITRIC-OXIDE) IN DIABETIC RENAL HYPERFILTRATION [J].
BANK, N ;
AYNEDJIAN, HS .
KIDNEY INTERNATIONAL, 1993, 43 (06) :1306-1312
[4]  
Cockram C. S., 2000, Hong Kong Medical Journal, V6, P43
[5]   Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease [J].
Colombo, MG ;
Andreassi, MG ;
Paradossi, U ;
Botto, N ;
Manfredi, S ;
Masetti, S ;
Rossi, G ;
Clerico, A ;
Biagini, A .
HEART, 2002, 87 (06) :525-528
[6]   IS NO AN ENDOGENOUS ANTIATHEROGENIC MOLECULE [J].
COOKE, JP ;
TSAO, PS .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :653-655
[7]   Acidic hydrolysis as a mechanism for the cleavage of the Glu298 → Asp variant of human endothelial nitric-oxide synthase [J].
Fairchild, TA ;
Fulton, D ;
Fontana, JT ;
Gratton, JP ;
McCabe, TJ ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26674-26679
[8]   eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm [J].
Fatini, C ;
Sofi, F ;
Sticchi, E ;
Bolli, P ;
Sestini, I ;
Falciani, M ;
Azas, L ;
Pratesi, G .
JOURNAL OF VASCULAR SURGERY, 2005, 42 (03) :415-419
[9]   Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy [J].
Fujita, H ;
Narita, T ;
Meguro, H ;
Ishii, T ;
Hanyu, O ;
Suzuki, K ;
Kamoi, K ;
Ito, S .
HORMONE AND METABOLIC RESEARCH, 2000, 32 (02) :80-83
[10]   NITRIC OXIDE-GENERATING VASODILATORS AND 8-BROMO-CYCLIC GUANOSINE-MONOPHOSPHATE INHIBIT MITOGENESIS AND PROLIFERATION OF CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
GARG, UC ;
HASSID, A .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1774-1777